Exhibit 99.1

LOGO

FOR IMMEDIATE RELEASE

 

Contacts:    Urologix:
   Fred B. Parks, Chairman and CEO
   (763) 475-1400

UROLOGIX REPORTS FOURTH QUARTER AND FISCAL YEAR 2006 RESULTS

MINNEAPOLIS – August 16, 2006 – Urologix

®, Inc. (NASDAQ:ULGX), today reported financial results for the fiscal fourth quarter and year ended June 30, 2006, both of which include $4.6 million of a non-cash income tax benefit to reduce the valuation allowance related to the Company’s deferred tax assets, and provided financial guidance for fiscal 2007.

Revenue for the fourth quarter of fiscal 2006 was $6.6 million, compared to $6.9 million in the same period of fiscal 2005. Treatment catheters accounted for 97% of revenue in the just completed quarter, compared to 95% of revenue in the prior-year period. Net earnings for the current quarter were $4.7 million, or $0.32 per diluted share, which includes $279,000 of equity-based compensation expense and the $4.6 million income tax benefit, compared to $706,000, or $0.05 per diluted share, for the fourth quarter of fiscal 2005. The Company adopted Statement of Financial Accounting Standard No. 123R (SFAS 123R), “Share-Based Payment”, in fiscal year 2006 as of July 1, 2005. Fiscal 2005 results do not include any equity-based compensation expense.

Annual revenue for fiscal 2006 of $25.9 million was relatively flat with fiscal 2005 revenue of $25.8 million. Net earnings for fiscal 2006 were $5.5 million, or $0.38 per diluted share, including $1.3 million of equity-based compensation expense and the $4.6 million income tax benefit noted previously, compared to net earnings of $2.8 million, or $0.19 per diluted share, in fiscal 2005.

Historically, Urologix has recorded a full valuation allowance on its deferred tax assets, the majority of which are net operating loss tax carry forwards which Urologix generated prior to achieving profitability. During the fourth quarter, it was determined that Urologix will more likely than not be able to realize a partial benefit from these deferred tax assets in the future, and as a result, recorded a non-cash income tax benefit of $4.6 million.

(more)


The following information was filed by Urologix Inc (ULGX) on Friday, August 18, 2006 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one year to another to evaluate Urologix Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Urologix Inc.

Continue

Never Miss A New SEC Filing Again


Real-Time SEC Filing Notifications
Screenshot taken from Gmail for a new 10-K Annual Report
Last10K.com Member Feature

Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news.

Continue

We Highlighted This SEC Filing For You


SEC Filing Sentiment Analysis - Bullish, Bearish, Neutral
Screenshot taken from Wynn's 2018 10-K Annual Report
Last10K.com Member Feature

Read positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q.

Continue

Widen Your SEC Filing Reading Experience


Increased Reading Area for SEC Filings
Screenshot taken from Adobe Inc.'s 10-Q Quarterly Report
Last10K.com Member Feature

Remove data columns and navigations in order to see much more filing content and tables in one view

Continue

Uncover Actionable Information Inside SEC Filings


SEC Filing Disclosures
Screenshot taken from Lumber Liquidators 10-K Annual Report
Last10K.com Member Feature

Read both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q

Continue

Adobe PDF, Microsoft Word and Excel Downloads


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats
Last10K.com Member Feature

Export Annual and Quarterly Reports to Adobe PDF, Microsoft Word and Excel for offline viewing, annotations and analysis

Continue

FREE Financial Statements


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshot of actual balance sheet from company 10-K Annual Report
Last10K.com Member Feature

Get one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports

Continue for FREE

Intrinsic Value Calculator


Intrinsic Value Calculator
Screenshot of intrinsic value for AT&T (2019)
Last10K.com Member Feature

Our Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not

Continue

Financial Stability Report


Financial Stability Report
Screenshot of financial stability report for Coco-Cola (2019)
Last10K.com Member Feature

Our Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity

Continue

Get a Better Picture of a Company's Performance


Financial Ratios
Available Financial Ratios
Last10K.com Member Feature

See how over 70 Growth, Profitability and Financial Ratios perform over 10 Years

Continue

Log in with your credentials

or    

Forgot your details?

Create Account